STAPLED HAEMORRHOIDOPEXY TO TREAT HEMORRHOIDS GRADE III AND IV- A SYSTEMATIC REVIEW AND META-ANALYSIS
Author(s)
Luque A1, Junqueira Junior SM1, Oliveira FM1, Oliveira D1, Cabra HA2
1Johnson & Johnson Medical Brazil, São Paulo, Brazil, 2Johnson & Johnson Medical, México, D.F., Mexico
OBJECTIVES: Hemorrhoids are not life-threatening, but they can cause itching, bleeding and pain, worsening quality of life. Stapled haemorrhoidopexy (SH) is a specially designed circular stapler used to cut out a strip of the tissue above the hemorrhoids in an area of the rectum that doesn’t feel much pain. The operation helps to reduce the hemorrhoids and it also helps shrink the remaining hemorrhoids by reducing their blood supply and makes them less likely to extend out of the anus. The aim of this study was to review and analyze the evidence of SH. METHODS: The electronic databases PubMed, EMBASE, The Cochrane Central Register of Controlled Trials, Wiley and OVID, were reviewed. The date limit was set to February 10th of 2015. The studies included were, RCT, the intervention being SH, and the comparison, conventional surgical techniques (CST). The primary outcome was to evaluate the patient acceptability and the second outcome was to evaluate length of stay, pain and time to return to work, only English language was recovered. Quality was assessed with GRADE scale. Meta-analysis was conducted with RevMan 5.3 for patient acceptability and length of stay, by random effect. RESULTS: : 26%, p=0.03.) Length of Stay was significantly lower in SH group (MD -0.74[-1.27;-0.21]; I: 96%, p<0.00001, n=1339). Adverse events were similar between strategies. SH offers less post-operative pain and fast return to work activities. CONCLUSIONS: SH is a safe and effective treatment to treat hemorrhoids grade III and IV, improve hospital efficiency and has higher patient acceptability.
Conference/Value in Health Info
2015-09, ISPOR Latin America 2015, Santiago, Chile
Value in Health, Vol. 18, No. 7 (November 2015)
Code
MD3
Topic
Clinical Outcomes
Topic Subcategory
Comparative Effectiveness or Efficacy
Disease
Gastrointestinal Disorders